BioCentury | May 1, 2020
Finance

As market’s upbeat April draws to close, Lyra becomes latest biotech IPO to surge

...Harvard University. Lyra’s shareholders include Perceptive Advisors, North Bridge Venture Partners, Polaris Partners, RA Capital, Intersouth Partners...
BioCentury | Jan 30, 2020
Financial News

Jan. 29 Financial Quick Takes: Black Diamond prices upsized IPO; plus Biohaven, Denali, Concert follow-ons, Lyra, Annovis, Histogen-Conatus and CellFE

...RA Capital Management, Soleus Capital, ArrowMark Partners, Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners...
BioCentury | Sep 28, 2018
Financial News

Perceptive leads Lyra's $29.5M series B

...Capital also participated, as did existing investors Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners...
BioCentury | Sep 26, 2018
Financial News

Perceptive leads Lyra’s $29.5M series B

...Capital also participated, as did existing investors Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners...
BioCentury | Jun 8, 2015
Financial News

Arsenal Medical completes venture financing

...completed: 2015-06-01 Type: Venture financing Raised: $16 million Investors: Polaris Partners; North Bridge Venture Partners; Intersouth Partners...
BioCentury | Jun 8, 2015
Financial News

480 Biomedical completes venture financing

...completed: 2015-06-01 Type: Venture financing Raised: $10.5 million Investors: Polaris Partners; North Bridge Venture Partners; Intersouth Partners...
BioCentury | Apr 20, 2015
Financial News

Innocrin Pharmaceuticals completes venture financing

...financing Raised: $28 million Investors: Eshelman Ventures; Novartis Venture Funds; Lilly Ventures; Hatteras Venture Partners; Intersouth Partners...
BioCentury | Nov 17, 2014
Emerging Company Profile

Treating CRPC failures

...of employees: 4 Funds raised: $14 million Investors: Novartis Ventures, Lilly Ventures, Hatteras Venture Partners, Intersouth Partners...
BioCentury | Nov 10, 2014
Financial News

Innocrin Pharmaceuticals completes venture financing

...2014-10-22 Type: Venture financing Raised: $14 million Investors: Novartis Option Fund; Lilly Ventures; Hatteras Funds; Intersouth Partners...
BioCentury | Nov 3, 2014
Finance

Metallic strategy

...funds. Six of Viamet's eight investors have committed to investing in Innocrin: Hatteras Venture Partners, Intersouth Partners...
Items per page:
1 - 10 of 116
BioCentury | May 1, 2020
Finance

As market’s upbeat April draws to close, Lyra becomes latest biotech IPO to surge

...Harvard University. Lyra’s shareholders include Perceptive Advisors, North Bridge Venture Partners, Polaris Partners, RA Capital, Intersouth Partners...
BioCentury | Jan 30, 2020
Financial News

Jan. 29 Financial Quick Takes: Black Diamond prices upsized IPO; plus Biohaven, Denali, Concert follow-ons, Lyra, Annovis, Histogen-Conatus and CellFE

...RA Capital Management, Soleus Capital, ArrowMark Partners, Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners...
BioCentury | Sep 28, 2018
Financial News

Perceptive leads Lyra's $29.5M series B

...Capital also participated, as did existing investors Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners...
BioCentury | Sep 26, 2018
Financial News

Perceptive leads Lyra’s $29.5M series B

...Capital also participated, as did existing investors Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners...
BioCentury | Jun 8, 2015
Financial News

Arsenal Medical completes venture financing

...completed: 2015-06-01 Type: Venture financing Raised: $16 million Investors: Polaris Partners; North Bridge Venture Partners; Intersouth Partners...
BioCentury | Jun 8, 2015
Financial News

480 Biomedical completes venture financing

...completed: 2015-06-01 Type: Venture financing Raised: $10.5 million Investors: Polaris Partners; North Bridge Venture Partners; Intersouth Partners...
BioCentury | Apr 20, 2015
Financial News

Innocrin Pharmaceuticals completes venture financing

...financing Raised: $28 million Investors: Eshelman Ventures; Novartis Venture Funds; Lilly Ventures; Hatteras Venture Partners; Intersouth Partners...
BioCentury | Nov 17, 2014
Emerging Company Profile

Treating CRPC failures

...of employees: 4 Funds raised: $14 million Investors: Novartis Ventures, Lilly Ventures, Hatteras Venture Partners, Intersouth Partners...
BioCentury | Nov 10, 2014
Financial News

Innocrin Pharmaceuticals completes venture financing

...2014-10-22 Type: Venture financing Raised: $14 million Investors: Novartis Option Fund; Lilly Ventures; Hatteras Funds; Intersouth Partners...
BioCentury | Nov 3, 2014
Finance

Metallic strategy

...funds. Six of Viamet's eight investors have committed to investing in Innocrin: Hatteras Venture Partners, Intersouth Partners...
Items per page:
1 - 10 of 116